Healthcare
Live Price
Offline$0.13
+4.00% today
1Y Change
-30.17%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Planet 13 Holdings Inc. (PLNH) is a Healthcare stock with a market cap of $50.00M and listed on OTC. The stock last traded around $0.13 and down 30.2% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -9.6%, EPS growth of -25.0%, a dividend yield of 0.0%. What stands out right now is revenue -9.6%, EPS -25.0%, free cash flow -209.2% with operating margin -57.2% and ROIC -42.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PLNH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLNH
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PLNH Max Drawdown
-73.46%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PLNH and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$119.5M
+14.3% YoY
FY Net Income
-$22.3M
+62.6% YoY
Free Cash Flow
-$82.1M
-250.0% YoY
Revenue Growth
-9.6%
EPS Growth
-25.0%
Gross Margin
38.4%
Net Margin
-61.2%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 105M | 116M | 99M | 105M | 119M |
| Gross Profit | 40M | 56M | 45M | 38M | 66M |
| Operating Income | -30M | -13M | -61M | -25M | -8M |
| EBITDA | -18M | 186K | -4M | -15M | -4M |
| Net Income | -65M | -48M | -74M | -60M | -22M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 23M | 12M | 52M | 62M |
| Total Assets | 152M | 207M | 152M | 220M | 217M |
| Total Liabilities | 101M | 94M | 44M | 43M | 43M |
| Shareholder Equity | 51M | 113M | 107M | 177M | 171M |
| Total Debt | 54M | 57M | 27M | 27M | 24M |
| Net Debt | 49M | 34M | 15M | -25M | -37M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
380K
+94.4% YoY
Capital Expenditures
82M
-389.4% YoY
Free Cash Flow
82M
-250.0% YoY
Key ratios
Gross Margin
38.4%
Operating Margin
-57.2%
Net Margin
-61.2%
ROE
-80.8%
Debt / Equity
1.06x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.